Showing results (201-210 of 1,318) with videos related to
Sort By:
Pageof 132
Clinical Neuropharmacology|May 6, 2011
Levodopa induces synthesis of nerve growth factor and growth hormone in patients with Parkinson diseaseThomas Müller, Reiner Hellwig, Siegfried MuhlackHandbook of Experimental Pharmacology|December 12, 2007
TLR9-mediated recognition of DNAThomas Müller, Svetlana Hamm, Stefan BauerFEMS Microbiology Ecology|August 29, 2009
Leucine arylamidase activity in the phyllosphere and the litter layer of a Scots pine forestThomas Müller, Marina Müller, Undine BehrendtPsychiatrische Praxis|March 9, 2023
[Early Psychiatric Patient Registration and the Case of Wuerttemberg]Christian Hofmann, Bernd Reichelt, Thomas MüllerApplied Optics|April 9, 2005
Particle extinction measured at ambient conditions with differential optical absorption spectroscopy. 1. system setup and characterizationThomas Müller, Detlef Müller, René DuboisApplied Optics|April 13, 2006
Particle extinction measured at ambient conditions with differential optical absorption spectroscopy. 2. Closure studyThomas Müller, Detlef Müller, René DuboisClinical Neuropharmacology|December 13, 2005
Levodopa intake increases plasma levels of S-adenosylmethionine in treated patients with Parkinson diseaseThomas Müller, Brian Fowler, Wilfried KuhnParkinsonism & Related Disorders|June 5, 2004
Apomorphine delays simple reaction time in Parkinsonian patientsThomas Müller, Sabine Benz, Horst PrzuntekJournal of the American Chemical Society|August 4, 2005
Sigma-delocalization versus pi-resonance in alpha-aryl-substituted vinyl cationsThomas Müller, Dominik Margraf, Yvonne SyhaDegenerative Neurological and Neuromuscular Disease|October 3, 2022
No Vitamin D Deficiency in Patients with Parkinson's DiseaseWilfried Kuhn, Georg Karp, Thomas MüllerPageof 132